Company Overview and News

8
ABB said to work with Credit Suisse, Dyal on power grid unit

2018-10-18 theedgemarkets
(Oct 18): ABB Ltd is working with advisers to prepare the potential separation of its power grid unit, people familiar with the matter said, which would be a strong indication the Swiss engineering company may divest the business worth more than US$10 billion.
DGLD CS GS UGLD GLSSP ABLZF JBK DSLV VIIX GSC CSSLF VIIZ TFG GSJ CSGKF ABB ZIV USLV TVIX GJS XIV

23
Enphase: Can This Small Cap Keep Climbing?

2018-10-02 seekingalpha
Solar microinverter producer Enphase Energy is in the middle of an impressive turnaround that has seen its stock increase more than 700% off its 2017 lows.
PCRFY JKS ABB SMTGY SPWR SMTGF 5GD ABLZF SRGRF SEDG ENPH

7
ABB Gains From Buyouts & Tactical Moves Despite High Costs

2018-10-02 zacks
We issued a research report on ABB Ltd. (ABB - Free Report) on Oct 1. This power and automation technology provider currently has approximately $50 billion market capitalization. Few growth drivers and certain headwinds, which might influence ABB, have been discussed below. Factors Favoring ABB Financial Performance & Earnings Outlook: ABB pulled off an average positive earnings surprise of 12.03% for the last four quarters.
FLOW ABB ESE ABLZF IPWR

42
Making Sense Of The Industrial Internet Of Things (Lessons From GE Digital)

2018-09-29 seekingalpha
The Industrial Internet of Things (IIoT) market is evolving and holds great potential for technology companies.
IBM ERIC ABB AMZN SIEGY VZ MSFT INTC

 
nVent Needs To Use Its Independence To Drive Growth

2018-09-27 seekingalpha
Spun off from Pentair, nVent is now free to reinvest some of its above-average margins into projects that can drive better revenue growth.
ABB

2
Cimpress to Acquire BuildASign to Boost Signage Businesses

2018-09-26 zacks
Recently,Cimpress N.V. (CMPR - Free Report) inked a definite agreement to acquire BuildASign — a premium online provider of signage, canvas wall décor and other types of large format products. This $280-million buyout is in sync with the company’s merger & acquisition strategy, and will likely strengthen its Print, Upload and Vistaprint businesses, moving ahead.
ABB ADES ATKR ABLZF

2
Cintas to Build New Laundry Operation Plant in Delta Township

2018-09-24 zacks
Cintas Corporation (CTAS - Free Report) has announced that it will conduct the groundbreaking ceremony for marking the construction site of its new manufacturing facility in Delta Township. The ceremony will be held on Sep 24 at 1:00 p.m., at the southwest corner of Mt. Hope Highway and S. Canal Road.
CTAS ABB ADES ATKR ABLZF TITN

1
Timken Boosts Inorganic Growth Trajectory With Rollon Buyout

2018-09-20 zacks
The Timken Company (TKR - Free Report) , successfully acquired premium engineered linear motion product manufacturer — Rollon Group, on Sep 18, Financial terms of the transaction have not been disclosed. Share price of the company spiked nearly 2% to $49.50 per share, after news of the acquisition surfaced.
ABB ABLZF TKR LB TRS

8
5 Industrials 'Safer' Dividend WallStars Gain 50% To 68.4% Per September Broker Estimates

2018-09-10 seekingalpha
WallStars are distinguished by positive broker target-price upsides. 'Safer' dividend industrials WallStar 1yr. target=gains for DAL, CAT, MAN, TTEC, CMRE, GMLP, DLX, CPA, GMLP. CPLP, & ATTO ranged 19.88%-68.45%.
CPLP HMLP CAT MAN SFL WM BGSF ABB CMRE GMLP CAJ ABLZF DLX DAL

3
7 Large Foreign Stocks With Big Upside for US Investors

2018-09-10 247wallst
2018 has been a strange time for investors. While the U.S. stock market sits close to all-time highs, many of the emerging and other developed markets nations have seen their shares take a beating. Wall Street analysts have made numerous calls signaling that there now may be more upside and opportunities in some larger international companies.
BLT BHPBF BP BP.A BP.B ABB BP BHP CCE ABLZF BBL TRI BHP MS BPAQF BHPLF

21
Top Research Reports: UnitedHealth, PepsiCo, Amgen & More

2018-08-14 zacks - 1
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features updated research reports on 12 major stocks, including UnitedHealth (UNH), PepsiCo (PEP) and Amgen (AMGN). These research reports have been hand-picked from roughly 70 reports published by our analyst team today.
FOX GD AMGN CQP LNG CVS CLH ABB 7018 PEP AMT CME ABLZF TXT UNH FOXA

1
ABB Poised on Solid Traction Across Markets, Risks Remain

2018-08-14 zacks
On Aug 14, we issued an updated research report on ABB Ltd (ABB - Free Report) .
ABB AIMC ABLZF AIT

21
General Electric: Is Flannery Throwing In The Towel?

2018-08-14 seekingalpha
New asset sales appear to show a continuation of the multi-year structural rebuilding strategy that has been laid-out by CEO John Flannery.
BHI ABB SBGSY GEC GE CATR CAT ABLZF GNE SBGSF

24
GE Is Preparing $1.5 Billion Sale of Power-Conversion Unit - Bloomberg

2018-08-10 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SBGSY DSLV GEC GE CATR VIIX DGLD CAT CSSLF VIIZ CS SBGSF BHI CSGKF ABB UGLD ABLZF GNE ZIV USLV TVIX XIV

112
7 High-Risk Dividend Stocks for Adventurous Income Investors

2018-08-08 investorplace - 2
Investing for income usually results in quieter, and lower-risk, investment strategies. The best dividend stocks tend to be more mature and lower-growth, which is why they distribute cash to shareholders rather than reinvesting it in their businesses. The goal of most income investors is to protect principal by buying quality companies who will grow dividends over time, rather than chasing ‘hot’ stocks with higher risk.
IBM HON GE F GEC ETH SCS ABB MAT AMZN FTRPR HON MLHR ABLZF TSLA GNE SPG EMR KNL SSI GMAN MAC FTR

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ABB / ABB Ltd. on message board site Silicon Investor.

Lazar-babble...... Lazar-babble...... Lazar-babble...... ABB (Asea Brown Boveri) ADR ABB (Asea Brown Boveri) ADR ABB (Asea Brown Boveri) ADR
Whou0027 s Roger Babb? Whou0027 s Roger Babb? Whou0027 s Roger Babb? Did Roger Rabbit blab to Roger Babb? Did Roger Rabbit blab to Roger Babb? Did Roger Rabbit blab to Roger Babb?
ABT: Abbott Laboratories ABT: Abbott Laboratories ABT: Abbott Laboratories ABT - Abbott Labs ABT - Abbott Labs ABT - Abbott Labs
Softechieu0027s KAABBOOOOMM Thread Softechieu0027s KAABBOOOOMM Thread Softechieu0027s KAABBOOOOMM Thread The Semi-Coherent Anti-American Babble Thread The Semi-Coherent Anti-American Babble Thread The Semi-Coherent Anti-American Babble Thread
Berger Tech Fund, GY SWC ITW Lord Abbett Large Cap GF Berger Tech Fund, GY SWC ITW Lord Abbett Large Cap GF Berger Tech Fund, GY SWC ITW Lord Abbett Large Cap GF DIZZY CITY-SPEAK..; psycho-babble translations DIZZY CITY-SPEAK..; psycho-babble translations DIZZY CITY-SPEAK..; psycho-babble translations
CUSIP: 000375204